Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S. V. Gridnieva"'
Publikováno v:
Ukrainian Therapeutical Journal. :44-56
The article highlights the role of intestinal barrier permeability in the pathogenesis of «metabolic diseases» (diabetes, obesity, etc.). It has been shown that normal intestinal microbiota plays an important role in maintaining the integrity of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::026e88326194be4dcd722f627831425b
https://doi.org/10.30978/utj2023-1-44
https://doi.org/10.30978/utj2023-1-44
Publikováno v:
Modern Gastroenterology. :55-67
Non‑alcoholic fatty liver disease (NAFLD) is a topical problem for the medicine worldwide, and its association with an «unhealthy» lifestyle and metabolic disorders is well established. The important role of dysbiosis of the intestinal microbiota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7471669933898f4d1b72377b201ff027
https://doi.org/10.30978/mg-2023-1-55
https://doi.org/10.30978/mg-2023-1-55
Publikováno v:
Modern Gastroenterology; № 4 (2020); 80—89
Современная гастроэнтерология; № 4 (2020); 80—89
Сучасна гастроентерологія; № 4 (2020); 80—89
Современная гастроэнтерология; № 4 (2020); 80—89
Сучасна гастроентерологія; № 4 (2020); 80—89
The article presents modern concepts on the role of the intestinal microbiome in the pathogenetic mechanisms of the development of metabolically associated diseases. The history of endotoxin discovery has been described. The multifaceted endotoxin pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac108bce6e3ae873d1f131af88dc9ef1
http://sgastro.com.ua/article/view/MG-2020-4-80
http://sgastro.com.ua/article/view/MG-2020-4-80
Publikováno v:
World of Medicine and Biology. 15:136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db0aaf8e06d9d97814caf35fbeb4faeb
https://doi.org/10.26724/2079-8334-2019-3-69-136-141
https://doi.org/10.26724/2079-8334-2019-3-69-136-141
Autor:
Volker, Gross, Ivan, Bunganic, Elena A, Belousova, Tatyana L, Mikhailova, Limas, Kupcinskas, Gediminas, Kiudelis, Zsolt, Tulassay, Libor, Gabalec, Andrey E, Dorofeyev, Jelena, Derova, Karin, Dilger, Roland, Greinwald, Ralph, Mueller, S V, Gridnieva
Publikováno v:
Journal of Crohn'scolitis. 5(2)
Background and aims Budesonide may be an effective therapy for mild-to-moderately active ulcerative colitis (UC). This study aimed to demonstrate non-inferiority for oral 9mg budesonide once daily (OD) versus 3g mesalazine granules OD. Methods This w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc9237f9d130fe1539caad7423e37cc6
https://pubmed.ncbi.nlm.nih.gov/21453882
https://pubmed.ncbi.nlm.nih.gov/21453882